SCHEMBL10954657

SCHEMBL10954657

Cc1ccc(C(CC(=O)Nc2ccccc2)c2ccc(C)cc2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.66
▸ BRD4 O60885 1/20 0.60
▸ LMNA P02545 3/20 0.57
▸ KMT2A Q03164 3/20 0.57
▸ MEN1 O00255 2/20 0.57
▸ CYP1A2 P05177 2/20 0.57
▸ CYP3A4 P08684 2/20 0.57
▸ CYP2D6 P10635 2/20 0.57
▸ CYP2C9 P11712 2/20 0.57
▸ CYP2C19 P33261 2/20 0.57
▸ CRHBP P24387 1/20 0.57
▸ HTT P42858 1/20 0.57
▸ CRHR2 Q13324 1/20 0.57
▸ NPSR1 Q6W5P4 1/20 0.57
▸ FNTA P49354 2/20 0.56
▸ FNTB P49356 2/20 0.56
▸ HPGD P15428 3/20 0.55
▸ POLB P06746 1/20 0.55
▸ GAA P10253 1/20 0.54
▸ TSHR P16473 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10948798 0.93 SMN1; SMN2 (0.65) SMN1; SMN2BRD4LMNAKMT2AMEN1
SCHEMBL10952227 0.86 LMNA (0.72) SMN1; SMN2BRD4LMNAKMT2AMEN1
SCHEMBL10952111 0.86 FNTA (0.65) SMN1; SMN2LMNAKMT2AMEN1CYP1A2
SCHEMBL10953466 0.86 FNTA (0.65) SMN1; SMN2LMNAKMT2AMEN1CYP1A2
SCHEMBL10950719 0.86 CA12 (0.58) SMN1; SMN2BRD4LMNAKMT2AMEN1
SCHEMBL10953663 0.84 CA12 (0.57) SMN1; SMN2BRD4LMNAKMT2AMEN1
SCHEMBL10952833 0.83 HTT (0.58) LMNAKMT2AMEN1CYP1A2CYP3A4
SCHEMBL10948604 0.83 LMNA (0.78) SMN1; SMN2LMNAKMT2AMEN1CYP1A2
SCHEMBL10946494 0.83 MEN1 (0.80) SMN1; SMN2LMNAKMT2AMEN1CYP1A2
SCHEMBL10949698 0.82 TACR1 (0.59) SMN1; SMN2LMNAKMT2AMEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4536346-A TREATMENT OF ATHEROSCLEROSIS AMERICAN CYANAMID COMPANY (US) 1985-08-20 — — US claimed
US-4536346-A TREATMENT OF ATHEROSCLEROSIS AMERICAN CYANAMID COMPANY (US) 1985-08-20 — — US disclosed
EP-0124791-A1 Aralkanamidophenyl compounds AMERICAN CYANAMID COMPANY (US) 1984-11-14 — — EP disclosed
Send feedback